NCT00259428 - EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS) | Biotech Hunter

Enrollment

615

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions

Atrial FibrillationAtrial Flutter

Interventions

DRUG

Dronedarone (SR33589)

oral administration

DRUG

placebo

oral administration

Trial Locations (12)

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Hørsholm

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi- Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Gouda

Sanofi-Aventis Administrative Office, Warsaw

Sanofi-Aventis Administrative Office, Barcelona

Sanofi-Aventis Administrative Office, Guildford